|Articles|August 10, 2022
- Pharmaceutical Executive-08-01-2022
- Volume 42
- Issue 8
Pharmaceutical Executive, August 2022 Issue (PDF)
Advertisement
Articles in this issue
about 4 years ago
The Silver Lining Of Innovation in Genetic Medicineabout 4 years ago
Navigating the Financial Meltdown for Biopharmaabout 4 years ago
The Potential of Proteomicsabout 4 years ago
Getting ‘Personal’ With Vaccine Developmentabout 4 years ago
A World of Opportunityabout 4 years ago
Has Biotech Bottomed Out—and is Recent Recovery Sustainable?Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
The Agentic AI Revolution in Biopharma
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5